Parsons James T. - Insider Non-Derivative Transactions at DiaMedica Therapeutics Inc. (DMAC) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Nov 21, 2025, Parsons James T.'s relationship to DiaMedica Therapeutics Inc. (DMAC) is Director, and currently has 75,854 shares of Voting Common Shares, no par value per share, and 87,854 shares of Common Stock.
The charts below show the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DMAC insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Parsons James T. - Insider Non-Derivative Transactions of DMAC Voting Common Shares, no par value per share
Parsons James T. - Insider Non-Derivative Transactions at DMAC
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 22, 2025 | M -- (Common Stock) | 12000 | 2.2 | 87854 |
| Jan 3, 2025 | Acquisition -- (Voting Common Shares, no par value per share) | 15917 | 5.34 | 75854 |
| Jan 3, 2024 | Acquisition -- (Voting Common Shares, no par value per share) | 21428 | 2.8 | 59937 |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.